SABIN A B
J Exp Med. 1952 Jul;96(1):99-106. doi: 10.1084/jem.96.1.99.
Neutralizing antibodies for Type 2 (Lansing) poliomyelitis virus were tested periodically in a group of 18 patients from whom Type 1 poliomyelitis virus was recovered. Data for homotypic neutralizing antibodies and Type 2 complement-fixing antibodies were also available on the majority of these patients. The results indicated that Type 2 neutralizing antibodies first appeared or significantly increased in titer in 11 of the 18 patients during the first 2 to 4 weeks after onset. In most patients the Type 2 neutralizing antibody either completely disappeared at 3 months (in one patient between 2 and 4 weeks) or dropped in titer, while the Type 1 or homotypic antibody persisted in high titer. These results are interpreted as indicating that the Type 1 and Type 2 poliomyelitis viruses share a common antigen, and that the heterotypic anti-body response is transitory while the homotypic neutralizing antibody persists for a longer time.
对一组18例曾分离出1型脊髓灰质炎病毒的患者定期检测2型(兰辛株)脊髓灰质炎病毒中和抗体。大多数患者也有同型中和抗体及2型补体结合抗体的数据。结果表明,18例患者中有11例在发病后的头2至4周内首次出现2型中和抗体或其滴度显著升高。在大多数患者中,2型中和抗体在3个月时(1例在2至4周之间)完全消失或滴度下降,而1型或同型抗体则持续保持高滴度。这些结果被解释为表明1型和2型脊髓灰质炎病毒具有共同抗原,异型抗体反应是短暂的,而同型中和抗体持续时间更长。